FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the use of a compound of the formula:
for treating one or several of the following GABA-mediated disorders: mood disorder, anxiety disorder, bipolar disorder, tremor or tinnitus in a subject in need thereof and for inhibiting or potentiating GABA receptor function in a subject suffering from one or several of the following GABA-mediated disorders: affective disorder, anxiety disorder, bipolar disorder, tremors or tinnitus.
EFFECT: obtaining of a new compound that is active against the GABA receptor and can be used to treat an indirect disorder.
27 cl, 5 tbl, 52 dwg, 71 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2014 |
|
RU2675855C2 |
| 19-NOR NEUROACTIVE STEROIDS AND METHODS OF USING THEM | 2014 |
|
RU2700264C2 |
| COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
| COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USE THEREOF | 2015 |
|
RU2699359C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2014 |
|
RU2754534C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF | 2012 |
|
RU2665571C2 |
| NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
| OXYSTEROLS AND THEIR APPLICATION METHODS | 2017 |
|
RU2754130C2 |
